Spots Global Cancer Trial Database for Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer
Official Title: A Phase II, Multicentre, Non-Comparative, Open-Label Study To Evaluate The Efficacy And Tolerability Of ZD1839 (Iressa™) In Asymptomatic Radio-Naive Patients With Brain Metastases From Non-Small Cell Lung Carcinoma (NSCLC) Who Have Relapsed Following Prior Chemotherapy
Study ID: NCT00234442
Interventions
Study Description
Brief Summary: The aim of the study is to determine if Iressa is effective in the treatment of Brain metastases from NCSLC
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Bologna, , Italy
Research Site, Orbassano, , Italy
Research Site, Parma, , Italy
Research Site, Rozzano, , Italy
Contact Details
Name: Lucio Crino, MD
Affiliation: Bologna, Italy
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
